| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Expansion of cancer care and control in countries of low and middle income: a call to action.
|
Lancet
|
2010
|
6.84
|
|
2
|
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.
|
Lancet
|
2011
|
5.76
|
|
3
|
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.
|
JAMA
|
2003
|
4.01
|
|
4
|
Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
|
J Natl Cancer Inst
|
2005
|
3.73
|
|
5
|
Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.
|
J Natl Cancer Inst
|
2003
|
3.67
|
|
6
|
Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.
|
J Clin Oncol
|
2005
|
3.47
|
|
7
|
Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496).
|
J Clin Oncol
|
2012
|
3.37
|
|
8
|
Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
|
J Natl Cancer Inst
|
2005
|
3.07
|
|
9
|
Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis.
|
J Clin Oncol
|
2002
|
2.88
|
|
10
|
Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.
|
J Clin Oncol
|
2002
|
2.63
|
|
11
|
Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.
|
J Natl Cancer Inst
|
2002
|
2.44
|
|
12
|
Randomized trial comparing two fractionation schedules for patients with localized prostate cancer.
|
J Clin Oncol
|
2005
|
2.06
|
|
13
|
Utility of serum tumor markers during surveillance for stage I seminoma.
|
Cancer
|
2012
|
2.05
|
|
14
|
Inverse relationship between biochemical outcome and acute toxicity after image-guided radiotherapy for prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2011
|
2.00
|
|
15
|
Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response.
|
Cancer Res
|
2007
|
1.75
|
|
16
|
Excellence in Radiation Research for the 21st Century (EIRR21): description of an innovative research training program.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.53
|
|
17
|
Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study).
|
Oncologist
|
2014
|
1.50
|
|
18
|
Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.46
|
|
19
|
Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer.
|
Clin Cancer Res
|
2012
|
1.41
|
|
20
|
The clinical features, management and prognosis of primary and secondary indolent lymphoma of the bone: a retrospective study of the International Extranodal Lymphoma Study Group (IELSG #14 study).
|
Leuk Lymphoma
|
2014
|
1.40
|
|
21
|
Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy.
|
Cancer
|
2010
|
1.40
|
|
22
|
Adjuvant carboplatin in stage I seminoma.
|
Lancet
|
2005
|
1.39
|
|
23
|
Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.28
|
|
24
|
Improving the TNM classification: findings from a 10-year continuous literature review.
|
Int J Cancer
|
2014
|
1.27
|
|
25
|
Image guided dose escalated prostate radiotherapy: still room to improve.
|
Radiat Oncol
|
2009
|
1.20
|
|
26
|
Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.20
|
|
27
|
Noncancer causes of death in survivors of testicular cancer.
|
J Natl Cancer Inst
|
2007
|
1.20
|
|
28
|
Radiotherapy for bladder cancer.
|
Urology
|
2007
|
1.10
|
|
29
|
Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors.
|
Blood
|
2005
|
1.09
|
|
30
|
Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2004
|
1.07
|
|
31
|
Online planning and delivery technique for radiotherapy of spinal metastases using cone-beam CT: image quality and system performance.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.05
|
|
32
|
Testosterone and erectile function recovery after radiotherapy and long-term androgen deprivation with luteinizing hormone-releasing hormone agonists.
|
BJU Int
|
2006
|
0.97
|
|
33
|
A phase II study of localized prostate cancer treated to 75.6 Gy with 3D conformal radiotherapy.
|
Radiother Oncol
|
2005
|
0.97
|
|
34
|
Testicular cancer survivors' supportive care needs and use of online support: a cross-sectional survey.
|
Support Care Cancer
|
2012
|
0.93
|
|
35
|
Canadian consensus guidelines for the management of testicular germ cell cancer.
|
Can Urol Assoc J
|
2010
|
0.92
|
|
36
|
Local radiotherapy induces homing of hematopoietic stem cells to the irradiated bone marrow.
|
Cancer Res
|
2007
|
0.91
|
|
37
|
The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496.
|
Br J Haematol
|
2013
|
0.91
|
|
38
|
Early stage gastric diffuse large B-cell lymphomas: results of a randomized trial comparing chemotherapy alone versus chemotherapy + involved field radiotherapy. (IELSG 4). [corrected].
|
Leuk Lymphoma
|
2009
|
0.87
|
|
39
|
Evolving concepts in stage I seminoma.
|
BJU Int
|
2009
|
0.87
|
|
40
|
A cinematic magnetic resonance imaging study of milk of magnesia laxative and an antiflatulent diet to reduce intrafraction prostate motion.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.85
|
|
41
|
Clinical application of high-dose, image-guided intensity-modulated radiotherapy in high-risk prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.85
|
|
42
|
Treatment-related toxicity and symptom-related bother following postoperative radiotherapy for prostate cancer.
|
Can Urol Assoc J
|
2010
|
0.84
|
|
43
|
Patient-specific PTV margins in radiotherapy for bladder cancer - a feasibility study using cone beam CT.
|
Radiother Oncol
|
2011
|
0.83
|
|
44
|
Treatment burden in stage I seminoma: a comparison of surveillance and adjuvant radiation therapy.
|
BJU Int
|
2013
|
0.83
|
|
45
|
Palliation by low-dose local radiation therapy for indolent non-Hodgkin lymphoma.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.83
|
|
46
|
Recurrent prostate cancer following external beam radiotherapy: follow-up strategies and management.
|
Urol Clin North Am
|
2003
|
0.81
|
|
47
|
Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long-term survivors of Hodgkin's disease: July 9-16, 2003, Bellagio, Italy.
|
Eur J Haematol Suppl
|
2005
|
0.80
|
|
48
|
Clinical and biochemical outcome of conventional dose radiotherapy for localized prostate cancer.
|
Can J Urol
|
2002
|
0.79
|
|
49
|
Clinical features, management and prognosis of multifocal primary bone lymphoma: a retrospective study of the international extranodal lymphoma study group (the IELSG 14 study).
|
Br J Haematol
|
2014
|
0.79
|
|
50
|
Fighting cancer with the internet and social networking.
|
Lancet Oncol
|
2008
|
0.79
|
|
51
|
Semiautomatic vertebrae visualization, detection, and identification for online palliative radiotherapy of bone metastases of the spine.
|
Med Phys
|
2008
|
0.78
|
|
52
|
'Evidence-based medicine: the time has come to set standards for staging'. Is a radical overhaul really needed?
|
J Pathol
|
2010
|
0.78
|
|
53
|
A single institution experience of extranodal natural killer/T cell lymphoma of nasal type.
|
Leuk Lymphoma
|
2015
|
0.77
|
|
54
|
A one-step cone-beam CT-enabled planning-to-treatment model for palliative radiotherapy-from development to implementation.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.76
|
|
55
|
eToolkits:improving pain management.
|
J Pain Palliat Care Pharmacother
|
2007
|
0.76
|
|
56
|
The global cancer epidemic: opportunities for Canada in low- and middle-income countries.
|
CMAJ
|
2012
|
0.75
|
|
57
|
Radiotherapy and organ preservation in bladder cancer: are we ignoring the evidence?
|
J Clin Oncol
|
2002
|
0.75
|
|
58
|
Re: Vikram, B., The PSA conundrum. [Radiother Oncol, 2004. 71(1): p. 1-2].
|
Radiother Oncol
|
2004
|
0.75
|
|
59
|
The effect of local breast radiotherapy on circulating CD34(+) cells.
|
Radiother Oncol
|
2011
|
0.75
|